Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1993-3-25
|
pubmed:abstractText |
The acute systemic and regional hemodynamic effects of dobutamine (5, 10, and 15 micrograms/kg/min intravenously), of enoximone (1, 1.5, and 2 mg/kg intravenously), and of the dobutamine-enoximone combination were compared in eight patients with severe congestive heart failure. Dobutamine and enoximone similarly and dose-dependently increased cardiac index and decreased systemic vascular resistance, right atrial pressure, and mean capillary wedge pressure. Dobutamine, but not enoximone, increased heart rate after 10 and 15 micrograms/kg/min. The combination of the two drugs caused a greater increase in cardiac index and a greater decrease in total peripheral resistance than did each drug alone. In the forearm vascular bed, brachial blood flow and brachial artery diameter were increased by enoximone significantly and dose-dependently and by dobutamine only at 5 micrograms/kg/min. Finally, the combination of the two drugs increased brachial blood flow but not brachial artery diameter to a larger extent than enoximone alone. Hepatosplanchnic and renal blood flows were not altered by any of the treatments. These results indicate that (1) enoximone exerts a significantly greater muscular vasodilator action than dobutamine; (2) the dobutamine-enoximone combination potentiates the systemic and brachial vasodilator effects of each drug; and (3) high doses of dobutamine (10 and 15 micrograms/kg/min) improve hemodynamics through their positive inotropic and chronotropic effects, whereas at low doses (5 micrograms/kg/min) a peripheral vasodilation also contributes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0002-8703
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
125
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
799-808
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8438709-Adult,
pubmed-meshheading:8438709-Aged,
pubmed-meshheading:8438709-Dobutamine,
pubmed-meshheading:8438709-Dose-Response Relationship, Drug,
pubmed-meshheading:8438709-Drug Therapy, Combination,
pubmed-meshheading:8438709-Enoximone,
pubmed-meshheading:8438709-Female,
pubmed-meshheading:8438709-Heart Catheterization,
pubmed-meshheading:8438709-Heart Failure,
pubmed-meshheading:8438709-Hemodynamics,
pubmed-meshheading:8438709-Humans,
pubmed-meshheading:8438709-Male,
pubmed-meshheading:8438709-Middle Aged
|
pubmed:year |
1993
|
pubmed:articleTitle |
Arterial hemodynamics and cardiac effects of enoximone, dobutamine, and their combination in severe heart failure.
|
pubmed:affiliation |
Department of Clinical Pharmacology, Hôpital de Bicêtre, France.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|